IOVA IOVANCE BIOTHERAPEUTICS INC
2026Q2 · CUSIP 462260100 · Sector: Healthcare & Biotech
Net holder growth weakened from last quarter
287 funds held IOVA at the end of 2026Q2, up 4 from the quarter before. Buying has come off its highs, but funds are not exiting. IOVA has had 11 buying rushes in its history, and the price moved -2.7% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.
How many funds owned it, quarter by quarter
Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.
What happened after each past buying rush 11 times in its history
| Quarter of the rush | How unusual then | Price, next 3 months | Price, next 6 months |
|---|---|---|---|
| 2026Q1 | Top 20% | — | — |
| 2024Q2 | Top 20% | -18.2% | -46.2% |
| 2024Q1 | Top 10% | +9.3% | -20.1% |
| 2023Q1 | Top 20% | -16.4% | -36.7% |
| 2021Q3 | Top 20% | -15.9% | -23.0% |
| 2020Q2 | Top 10% | +29.4% | +63.0% |
| 2020Q1 | Top 5% | -20.3% | +3.2% |
| 2019Q4 | Top 20% | +52.2% | +16.6% |
These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.
Show all the numbers (large funds, value held, options…) ▾ Collapse ▴
These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.
8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.
Email me the next update
2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.